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Glucocorticoids modulate renal glucocorticoid receptors
and Na-K ATPase activity
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Glucocorticolds modulate renal glucocorticoid receptors and Na.K
ATPase activity. Primary cultures of mouse renal tubular epithelial cells
were used to study the effect of hydrocortisone on the regulation of
glucocorticoid receptors (GR) and on sodium—potassium adenosine
triphosphatase (Na-K ATPase) activity. A GR assay was developed and
performed directly on cell monolayers maintained in serum—free me-
dium to which hydrocortisone at 5 riM, 50 flM, and 5 x l0 M was
added. Compared with control cells grown in medium without hydro-
cortisone, GR levels per cell decreased by 50% after 48 hours of growth
in medium containing 5 flM hydrocortisone. After 96 hours of cell
treatment with supraphysiologic hydrocortisone concentrations (50 flM
or 5 x lO M), GR levels decreased to 28% of control values. In all
hydrocortisone treatment groups there was an inverse relation between
GR concentrations and Na-K ATPase activity. Binding of cell GR by
the addition of the antiglucocorticoid RU 38486 in hydrocortisone—
supplemented medium eliminated the glucocorticoid—induced stimula-
tion of Na-K ATPase activity. These results demonstrate a time— and
dose—dependent effect of glucocorticoids on GR binding activity and a
direct relation between this receptor—hormone interaction and Na-K
ATPase activity in intact renal tubular epithelial cells.
Glucocorticoid hormones exert an important influence on
normal growth and differentiation in a variety of organs, includ-
ing kidney, lung, and intestine U—li]. Several studies have
suggested that such effects are mediated by modulation of the
level or activity of certain key enzymes involved in metabolic
and physiologic processes. Investigations have shown that
Na-K ATPase activity is induced by glucocorticoids, especially
in immature or developing rat proximal tubules, and have led to
speculation that "the inductive effect is probably mediated via
glucocorticoid receptors" [12,13]. Recent studies have demon-
strated that glucocorticoids induce proximal tubular cyst for-
mation in murine metanephric organ culture [14,151 and that
such tubular maldevelopment is mediated by increased Na-K
ATPase activity [161. In the aggregate, these data suggest that
glucocorticoids and Na-K ATPase activity play a role in abnor-
mal and normal renal growth and development.
Although it is clear that glucocorticoids stimulate renal tubu-
lar Na, K-ATPase activity, little is known of the biochemical
mechanism of such enzyme induction. Presumably, these en-
zymatic changes are one of many biologic responses of tubular
Received for publication October 16, 1986
and in revised form March 12, 1987
© 1987 by the International Society of Nephrology
epithelial cells following interaction of glucocorticoids with
specific cytosolic receptors. These receptors have been shown
to be localized mainly in the proximal tubules and the distal
convoluted tubule—cortical collecting duct regions [17—19].
However, no study has correlated glucocorticoid receptor (GR)
binding with Na-K ATPase activity. Furthermore, there is
limited information on the effects of glucocorticoid treatment on
renal tubular epithelial cell GR concentrations and Na-K
ATPase activity. Therefore, we investigated the effect of
glucocorticoids in regulating GR binding activity in primary
cultures of mouse tubular epithelial cells and related changes in
GR concentration to specific Na-K ATPase activity.
Methods
Timed pregnant, Swiss—Webster albino mice were purchased
from Hilltop Laboratories (Scottdale, Pennsylvania, USA). The
basal culture medium (SSFD) consisted of a 50/50 mixture of
Dulbecco's modified Eagle's medium and Ham's F-i2 medium
supplemented with 15 mrvi Hepes buffer, 1.2 mglml NaHCO3,
100 lU/mI penicillin, 100 p.g/ml streptomycin, 0.25 rg/ml am-
photericin B, and 5 x 10-8 M selenium. For K1 growth medium
without hydrocortisone, SSFD was supplemented with 5 rg/m1
insulin, 5 jsg/ml transferrin, 25 ng/ml prostaglandin E1, and 3.4
ng/ml triiodothyronine. [6,73H(N)]-dexamethasone, specific
activity 45.8 Ci/nmol, was obtained from New England Nuclear
Co. (Boston, Massachusetts, USA). A crystalline preparation
of unlabeled dexamethasone was provided by Merck Sharp &
Dohme Research Laboratories (West Point, Pennsylvania,
USA). RU 38486 was from the Roussel—Uclaf Research Center,
Romainville, France. Unlabeled steroids, protease inhibitors,
and chemicals used in the buffers and ATPase assay were
obtained from Sigma Chemical Co. (St. Louis, Missouri, USA).
Monoclonal antibody to M6 antigen derived from mouse cere-
bellum neurites, which cross—reacts with mouse proximal tubu-
lar epithelial brush border, was from Dr. Carl Lagenaur (De-
partment of Pathology, University of Pittsburgh) and prepared
by his previously published methods [20].
Primary mouse kidney cell culture
The basic culture conditions used to grow kidney tubular
epithelial cells were described by Taub and Sato [21,22]. The
following minor modifications in technique were utilized in
order to obtain single cells, rather than tubular fragments.
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Fig. 1. Confluent monolayer of tubular epithelial cells cultured in
hydrocortisone—deprived serum—free medium for 6 days (unstained;
270X).
Ten—day—old mice were killed by cervical dislocation, and the
kidneys were aseptically removed, trimmed of nonrenal tissue,
decapsulated, and placed in SSFD. After mincing into 1-mm
pieces, the tissue was suspended in SSFD containing Type IV
collagenase (Cooper Biochemical Inc., Malvurn, Pennsylvania,
USA) at a final concentration of 0.1 mg/mI. After 10 minutes of
tissue digestion under constant stirring in a 37°C bath, a 0.1%
solution of soybean trypsin inhibitor was added. Stirring con-
tinued for another five minutes, then nephron fragments were
skimmed from the upper fluid portion and more collagenase
solution (0.1 mg/mI) was added to the digestion mixture. The
process was repeated every 10 minutes until sufficient nephron
fragments were collected. These were pooled, washed in SSFD,
and centrifuged for seven minutes at 800 x g. The nephron
fragments were then resuspended in SSFD and passed through
a sterile 61-pm nylon sieve (Tetcol Corp., Elmsford, New
York, USA), which retains glomeruli and undigested tissue.
The filtered tubules were washed in SSFD, centrifuged, and the
pellets were treated for five minutes with 0.1% trypsin EDTA in
Hank's balanced salt solution followed by addition of 0.1%
trypsin inhibitor. The resultant cellular preparation was centri-
fuged, washed with SSFD, and centrifuged again, and the cell
pellets were resuspended in K1 medium without glucocorticoids
at a density of 1 x i0 cells per ml. Two-ml portions of this cell
suspension were aliquoted into Falcon 35 mm tissue culture
dishes and placed in an incubator with mixed air-5% CO2 at 37
0.5°C and 95% humidity. The medium was changed after the
initial 24 hours of incubation and then routinely every 48 hours.
Confluent monolayers were consistently obtained at 84 to 108
hours in culture (Fig. 1).
Glucocorticoid receptor measurement
Monolayers of primary mouse kidney tubular epithelial cells
consisting of 0.8 to 1.0 x 106 cells per dish were washed three
times with 2 ml cold phosphate—buffered saline (PBS). Equilib-
rium conditions for the glucocorticoid—receptor binding assay
were determined after incubation of these cells at 4°C for
variable times in [3H]-dexamethasone in PBS. The equilibrium
conditions adopted for the standard routine binding assay were
as follows: monolayers were incubated at 4°C for 2.5 hours with
a total reaction volume of 0.6 ml consisting of PBS and a range
of final concentrations of [3H]-dexamethasone (2.5 to 80 nM) in
the presence (nonspecific) and absence (total binding) of a
100-fold excess of unlabeled dexamethasone. The monolayers
were then washed three times with cold PBS to remove
unbound labeled and unlabeled dexamethasone. Radioactivity
was extracted with absolute ethanol and Triton in PBS. The
emulsified contents were poured into Aquassure scintillation
fluid (New England Nuclear Co., Boston, Massachusetts, USA)
and counted in a Packard Ti-Carb 4640 scintillation counter.
Specific binding was then analyzed, and the concentration of
receptor—steroid complexes and the dissociation constant (Kd)
were determined by the method of Scatchard [23]. The number
of GR per cell was calculated by dividing the GR number per
culture dish by the mean cell number counted in a hemocytom-
eter after trypsin treatment of five separate culture dishes at
each of the four days of growth in the respective hydrocortisone
concentrations.
Specificity of GR binding was evaluated by measuring [3H]-
dexamethasone binding in the presence of several unlabeled
steroids including dexamethasone, corticosterone, hydrocor-
tisone, aldosterone,and testosterone. Mouse kidney cells were
incubated for 2.5 hours at 4°C with 60 flM [3H}-dexamethasone
alone and in the presence of either 1-, 10-, or 100-fold excess
concentration of each of these steroids. Binding of [3H]-
dexamethasone was measured as per the routine assay.
The GR-ligand binding data and Scatchard plot analyses were
obtained in 144-hour-old cultures grown in K1 medium devoid
of hydrocortisone. Subsequent experiments used the standard
receptor assay to measure GR in primary cell cultures main-
tained in various concentrations of hydrocortisone. Starting at
120 hours of culture, hydrocortisone was added to the K1
medium at 5 nM, 50 flM, and 5 x 10 M final concentrations. To
provide relatively constant hydrocortisone concentrations, the
medium was changed daily thereafter. Receptor levels from
hydrocortisone—treated cells were compared with levels in cells
maintained without hydrocortisone daily for 96 hours.
Determination of Na-K ATPase activity and DNA
Cells in 35-mm dishes were washed two times with PBS,
harvested by scraping, washed twice with 0.2 M sucrose-0.02 M
Tris base buffer at 4°C, and resuspended in the same buffer.
Cells were chilled on ice, then disrupted in a Kontes disposable
microhomogenizer. Aliquots of cell extract were then used to
measure DNA by the method of Nordling and Silja [24], tissue
protein by the method of Lowry et al [25], and Na-K ATP4se by
our previously described modification of the linked pyruvate
kinase—lactate dehydrogenase kinetic spectrophotometric meth-
od [16,261. For Na-K ATPase measurement, 15 sl of extract
(cells from four plates homogenized in 300 d of buffer) were
added to duplicate cuvettes containing the Na-K ATPase reac-
tion mixture and two additional cuvettes containing ouabain at
a final concentration of 3.0 mM in the same reaction mixture.
The Na-K ATPase reaction mixture contained final concentra-
tions of 100 m NaC1, 10 mrvi KC1, 2.5 m MgC12, 1 m
Tris-ATP, 1 ms tri(cyclohexylammonium)phosphoenolpyru-
vate, 30 mst imidazole-HC1 buffer (pH 7.3), 0.15 mr.i NADH, 50
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Fig. 2. A. Saturation of [3H]-dexamethasone binding sites as a func-
tion of steroid concentration in primary cell cultures grown for 7 days
in serum—free medium without glucocorticoids. B. Scatchard plot of the
binding activity. Kd = dissociation constant. r = correlation coefficient
of linear regression line.
sg/ml of lactate dehydrogenase, and 30 sg/ml of pyruvate
kinase. After initial stabilization, the oxidation of NADH was
monitored at 340 nm in a Perkin—Elmer Lambda 3 Spectropho-
tometer. The temperature of the reaction was maintained at 37
0.1°C by a thermoelectrically—controlled cell holder. ATPase
activity was calculated from the rate of change of optical
density using the L3CP kinetic software program of the
Perkin—Elmer 3600 Data Station, and expressed as mol/min/tg
of DNA. Specific Na-K ATPase activity was determined as
ouabain—sensitive ATPase activity, and computed from the
difference between the reaction rate with and without the
addition of ouabain. The amount of ouabain added to the
reaction mixture (3.0 m final concentration) was two to three
times greater than the concentration needed to produce maxi-
Dexamethasone Hydrocortisone Aldosterone
Corticosterone Testosterone
Fig. 3. Specificity of hormone binding to glucocorticoid receptors in
renal cells in the presence of 60 nM [311]-dexamethasone alone and with
either a 1-, 10-, or 100-fold excess of unlabelled competing steroid.
Values are expressed as a percent of the specific binding of PH]-
dexamethasone.
ma! inhibition of Na-K ATPase in our mouse primary renal cell
culture. This was determined by performing a series of prelim-
inary ouabain inhibition experiments in which cell extracts were
incubated with and without ouabain at final concentrations
ranging from 0.01 to 3.0 mtvi.
Additional studies
To assess whether the change in Na-K ATPase activity afterl max hydrocortisone treatment is receptor—mediated, an antigluco-
corticoid, RU 38486, with an affinity for GR three times that of
dexamethasone, was added at 5 and 20 nM final concentrations
to medium supplemented with 50 nm hydrocortisone [27].
Electron microscopy and immunofluorescence were per-
formed by standard techniques to study the morphology and
antigenic determinants of cultured cells [201. For the latter
studies, cells from the original cell suspension used to seed the
culture dishes, or cells scraped from culture plates after 72 and
120 hours in culture, were placed in 4% formalin and subse-
quently washed and incubated with fluorescein—tagged mono-
clonal antibody to M6 antigen.
Statistical methods
Statistical comparisons were made utilizing the difference
between the means of paired samples (paired t-test) as indicated
in Results.
Results
The tissue preparation after collagenase digestion and filtra-
tion through the 61 pm mesh showed tubular fragments and
minimal contamination by glomeruli. Following trypsin diges-
tion, 60 to 70% of the resultant monocellular preparation
showed positive immunostaining for M6 antigen, confirming
their proximal tubular origin. This was further confirmed by
electron microscopic examination showing that a similar pro-
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Table 1. Glucocorticoid receptor concentration [GR/cell or (%) of control] and ATPase [mol/j.g DNA X i0 or (%) of control] in mouse,
renal tubular epithelial, primary cell cultures grown for 24 to 96 hours in a chemically defined medium containing various concentrations of
hydrocortisone
24 Hours
N=4
48 Hours
N=4
72 Hours
N=3
96 Hours
N=3
.
Hydrocortisone
ATPase ATPase ATPase ATPase
concentration Gr Total Specific GR Total Specific GR Total Specific GR Total Specific
None (control) 103,413 5.91 1.88 113,354 5.70 1.60 109,458 4.81 1.42 106,200 4.89 1.31
Snm 91621b
(89)
6.15 1.98
(104) (105)
66,510c
(59)
5.46 175b
(96) (110)
56,859'
(52)
6.06 179b
(126) (126)
5l754C
(49)
6.64 182b
(135) (139)
50 nm
5 x l0 79448b(77)67,698
(65)
7.56 2.46
(128) (131)
8.60 2.76b
(146) (147)
54,904c
(48)
48598d
(43)
797 31d
(140) (144)
8.24 251d
(145) (157)
42081d
(38)
28,494"
(26)
8.97 2.46c
(186) (173)
10.08 2.82c
(210) (199)
29439d
(28)
21,046"
(20)
11.75 3.60c
(240) (275)
12.75 4.l9'
(261) (320)
Specific ATPase refers to ouabain inhibitable or Na-K ATPase
b P < 0.05 relative to control
P < 0.01 relative to control
d P <0.001 relative to control
portion of these cells had a brush border. The immunofluores-
cence staining for M6 antigen and the brush border could not be
detected after three days of growth. As shown in Figure 1, the
primary cell cultures had excellent morphology and were as-
sessed to have 98 to 100% viability by trypan blue dye exclu-
sion. The cells were free of fibroblasts and contained many
vesicles and mitochondria indicative of active transport of
solute and fluid. Numerous mitotic figures were present. These
characteristics of the tubular epithelial cells were retained for 10
to 14 days in primary culture after which time overall viability
deteriorated rapidly. Hence, only confluent primary cultures at
five to nine days of growth were used in all experiments.
Representative results of GR-dexamethasone binding data
and Scatchard plot analysis in cells cultured from 10-day—old
mice are shown in Figure 2. The data indicate that the apparent
Kd of the GR-dexamethasone binding is 23 5.5 n (mean
SD; N = 4) with a maximal binding capacity of 136,000 14,000
receptors/cell. This corresponded to a binding capacity of 5.65
0.94 pmol/mg DNA. The correlation coefficients of the
Scatchard regression lines ranged from —0.92 to —0.98% com-
pared with —0.80 to —0.90% in studies obtained when GR
assays were performed using single cells in test tubes, rather
than in culture dishes (unpublished data).
Competition experiments showed that the inhibition of [3H]-
dexamethasone binding was greatest with unlabeled dexameth-
asone, followed by corticosterone and hydrocortisone (Fig. 3).
The mineralocorticoid steroid, aldosterone, competed with
[3H]-dexamethasone for binding to the GR only when 100-fold
excess concentrations were used, whereas the nongluco-
corticoid steroid, testosterone, had minimal effect on [3H]-
dexamethasone binding only when 100-fold excess concentra-
tions were used. Thus, receptor binding was highly specific for
glucocorticoid steroids.
The effect of various concentrations of hydrocortisone on
receptor number is shown in Table 1. Receptor number re-
mained essentially unchanged during the 96 hours of growth
without hydrocortisone (total culture time of 9 days). After 24
hours in 5 nt'i hydrocortisone there was a reduction in GR
binding, which, on further treatment for 72 and 96 hours,
decreased and stabilized at about 50% of the GR level of cells
grown without hydrocortisone. When higher concentrations of
Time in culture, hrs
Fig. 4. Schematic representation of data from Table I highlighting the
effect of hydrocortisone on glucocorticoid receptor binding activity and
Na-K ATPase activity. The inverse relation between glucocorticoid
binding activity and Na-K ATPase activity is evident in hydrocorti-
sone—treated cells. Symbols are: ( ) GR; (— . —) ATPase; (0)
control; (•) S nM HC; (A) 50 nt.i HC; (•) 5 x l04M HC.
hydrocortisone were used (50 n and 5 x 10 M), the reduction
of GR binding per cell was more precipitous and remained
significantly lower (P < 0.01 and < 0.001 respectively), than
control values after 24 hours of treatment. Mter attaining
confluence, the cell number remained constant during the
subsequent 24 to 96 hours in control cultures or in cultures
treated with 5 or 50 nM hydrocortisone concentrations. How-
ever, a 10 to 20% decrease in cell number was observed in cells
grown in 5 x io- M hydrocortisone or 50 nM hydrocortisone
plus 20 nM RU 38486.
ATPase activity was measured in parallel to GR determina-
tions (Table 1). An inverse relationship between GR concentra-
tion and the levels of total and specific Na-K ATPase activities
was found at all assay points. These results are highlighted in
Figure 4. In control cultures the GR binding activity remained
relatively constant while Na-K ATPase activity showed a
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Table 2. Modulation of renal tubular epithelial cell glucocorticoid—
receptor binding activity and Na-K ATPase activity after treatment
with RU 38 186 for 48 hoursa
Experiment
Glucocorticoid
receptors
receptors/cell
(% of control)
Na-K ATPase
mol/gDNA x l0
(% of control)
1.
2.
3.
4.
Control (No HC or RU)
50 flM HC (No RU)
50 nM HC + 5 nM RU
50 aM HC + 20 flM RU
106,894 5,041
51,844 4,484 (48)"
26,357 2,770 (25)b
5,165 1,730(5)"
1.52 0.24
1.87 0.13 (123)
1,10 0.23" (72)
1.04 0.18" (68)
a Results are the mean SD of 3 separate experiments.bPaired (-test analysis shows a significant decrease (P < 0.05) in GR
between controls and each of the three experimental groups, and also
between Na-K ATPase activity between controls and experimental
groups 3 and 4. Both GR and Na-K ATPase activity were significantly
lower (P < 0.05) in experiment 4 as compared to experiment 2.
progressive decline over 96 hours of culture. With physiologic
levels of hydrocortisone (5 nM), both the OR reduction and
Na-K ATPase activity increment stabilized after 48 hours in
culture. After the addition of either 50 flM or 5 X iO— M
hydrocortisone to the growth medium, cell Na-K ATPase
activity appeared to reach maximal levels (275 to 320% of
control values) after 96 hours of culture. Hydrocortisone con-
centrations greater than 5 flM were associated with near maxi-
mal decreases in GR by 72 hours of culture, whereas Na-K
ATPase activity increased further by 96 hours of culture.
After 48 hours of cell growth in medium containing final
concentrations of 50 nM hydrocortisone, and 20 nM RU 38486,
OR decreased to 5% of levels measured in controls, or 10% of
levels measured in cells treated only with 50 nM hydrocortisone
(Experiment #2, Table 2). The effect of 5 flM concentrations of
RU 38486 in decreasing OR binding activity was intermediate to
that observed with 20 nM RU 38486. Notably, this decrease in
assayable OR caused by RU 38486 was associated with a
signiiIcant decrease (P < 0.05), rather than an increase, in Na-K
ATPase activity in hydrocortisone—treated cells.
Discussion
The current method used to prepare the cells for culture,
together with the immunofluorescence and electron micro-
scopic studies, indicate that the initial cell innoculum consisted
mainly of proximal tubular epithelial cells and, to a lesser
degree, of other tubular and glomerular cells. Notably, a small
decrease in cell number over and above cell loss from senes-
cence occurred over four days of culture in medium containing
5 X 10 M hydrocortisone concentrations or RU 38486, sug-
gesting that such supraphysiologic levels may be deleterious to
cell growth. Similar impairment in cell proliferation has been
reported previously [28,29], and these effects are probably
related to known biochemical consequences of excess gluco-
corticoids such as decreased amino acid and uridine incorpora-
tion, reduction of cell ATP production, and generalized de-
creases in protein synthesis [6—9,30,31].
The first objective of the current study was to demonstrate
specific binding of glucocorticoids to receptors present in
cultured cells. The binding data were consistent with a single
class of saturable receptor and linear Scatchard plots, the mean
Kd of the OR-dexamethasone complexes being 23 5.5 nst
(mean SD). Further, competition experiments showed that
the specificity of binding in cells was qualitatively similar to that
assayed of cytosolic preparations [32]. There is no available
methodology for the measuremnt of OR in cultured renal
tubular epithelial cells and no such measurements by which to
compare the current results. However, the Kd values in the
present study are comparable to those previously reported
using fresh preparations of rat nephron segments [17—19] and of
cultured pituitary AtT-20 cells, leukocytes, and hepatocytes
[33—37]. The number of receptor binding sites per cell was
markedly influenced by the concentration of and time of expo-
sure to hydrocortisone in the growth medium. Without
hydrocortisone, the receptor concentration remained near a
level of 110,000 receptors/cell from days 5 to 9 of incubation. By
contrast, GR levels stabilized at about 50% in cells grown in
physiologic hydrocortisone concentrations (5 nM), and declined
significantly over four days of growth in media containing  50
n concentrations of hydrocortisone. Since saturation of GR
routinely occurs at hydrocortisone concentrations exceeding 30
nM, it is not surprising that the changes in GR number differed
little in cells grown in 50 n and 5 X i0 M hydrocortisone
concentrations. Thus, primary cultures of mouse renal tubular
epithelial cells can increase GR binding activity in response to
glucocorticoid deficiency or to down—regulate GR binding ac-
tivity after 24 hours uf exposure to hydrocortisone concentra-
tions 10-fold higher than physiologic levels (50 nM).
With respect to regulation of receptor by high—affinity hg-
ands, it is important to distinguish occupation by unlabeled
ligand from true decreases in receptor number. Such differen-
tiation is possible by exchange assays applied to GR measure-
ments in cytosol [38—40]. Exchange techniques applied to cells
are much less reliable [33,41]. Cidlowski and Cidlowski found
qualitatively similar decreases in GR binding activity after six
days of growth of HeLa S3 cells with various concentrations of
unlabeled dexamethasone [33]. Using a cell washing procedure
to remove receptor—bound steroid, they determined that this
OR decrease was not the result of simple receptor occupation.
Similar experiments were not performed in the current study.
However, because dexamethasone binding to cell GR occurs
within two hours at 37°C [34,42], receptor occupation cannot
explain our results: no free or assayable receptor would have
been available after more than 24 hours of cell preincubation at
37°C with saturating concentrations of unlabeled glucocorti-
coids (30 nM).
The high number of receptors per cell in the current study is
unlikely to represent the true OR concentrations of renal
tubular epithelial cells in vivo, because lower numbers have
invariably been reported in glucocorticoid target tissues. How-
ever, a similarly high receptor binding activity has been re-
ported in cultured hepatoma cells in which the mean maximal
nuclear binding was 4.0 pmollmg DNA and the estimated
receptors per cell were over 100,000 [41]. In the current study,
the receptor number may have been augmented by the use of
primary, rather than high—passage, cell cultures, and by a high
proportion of cells in the S phase of the cell cycle [28,29].
Nevertheless, the time course of down—regulation and the
relative decrease in glucocorticoid binding capacity in our study
parallel the findings of several other studies using cultured cells
of diverse origin [33,35,36,43—46]. Moreover, as in other studies
of down—regulation, cell OR values stabilized at 20 to 25% of
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control values after four days of growth in saturating concen-
trations of hydrocortisone [33,35,47]. Thus, even though GR
concentrations measured under culture conditions are consid-
erably higher than representative values from tubular epithelial
cells in vivo, the data clearly indicate that mouse renal tubules
are glucocorticoid—sensitive and provide further support for an
agonist—dependent receptor down—regulation that is dose— and
duration—dependent. Further, the amplification in GR number
in cultured cells as compared to in vivo GR measurements may
serve to discern subtle effects of various agents in regulating
cell GR numbers.
The previous finding of elevated total and ouabain—inhibitable
Na-K ATPase activity in organ culture explants of hydrocorti-
sone—induced polycystic kidneys led us to believe that measure-
ments of this enzyme might provide an index of the biologic
expression of glucocorticoids in renal tissue [15,16,48]. How-
ever, in these and in other studies in which renal Na-K ATPase
activity increased in response to glucocorticoid administration
[17,49—60], it was not established whether increased Na-K
ATPase activity was directly related to glucocorticoid binding
to GR, or whether Na-K ATPase was increased by an indirect
effect of GR binding or by receptor—independent steroid actions
[61]. The present results provide the first evidence demonstrat-
ing a dose— and time-dependent effect of glucocorticoids in
simultaneously modulating, intracellular GR binding activity
and stimulating total and ouabain—inhibitable Na-K ATPase
levels in primary renal tubular epithelial cell cultures. The time
lag in glucocorticoid—induced stimulation of Na-K ATPase
activity in the present study is very similar to that reported in
previous studies using proximal tubular cells in which GR levels
were not measured and only speculated to be increased [12,13].
The decrease in Na-K ATPase levels in control cells as a
function of culture—age may indicate that these cells ap-
proached their growth plateau. In the current studies,
glucocorticoid—induced gluconeogenesis together with limited
substrate and oxidative phosphorylation, present under cell
culture conditions, might have produced a net cell ATP deple-
tion, thereby reducing receptor phosphorylation and binding
activity [62—66]. However, previous data and the present find-
ings suggest that ATP depletion or decreased GR binding would
independently reduce, rather than stimulate, Na-K ATPase
activity [62—73].
In the current study, the glucocorticoid antagonist RU 38486
was used as a molecular probe, to demonstrate whether the
biologic effect of glucocorticoids is mediated by OR, rather than
by a receptor—independent process [74,75]. RU 38486 was
shown to reduce glucocorticoid binding to GR by about 95%
and simultaneously to prevent the stimulation of total and Na-K
ATPase activities by hydrocortisone. This supports the hypoth-
esis that the non-specific stimulation of total and Na-K ATPase
activities by glucocorticoids is receptor—mediated.
Our study indicates that primary cultures of mouse kidney
tubular epithelial cells are a useful system for the controlled,
systematic study of glucocorticoid receptors and the biologic
effects of receptor binding. From these data, we speculate that
OR-mediated modulation of renal Na-K ATPase may produce
many of the alterations in solute and fluid transport associated
with glucocorticoid use, and may be a regulatory factor in
glucocorticoid-induced renal teratogenesis [14—16].
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